New hope for controlling severe seizures in kids and adults
NCT ID NCT05066217
Summary
This study is testing whether a drug called clemizole, when added to a patient's current medications, can help reduce seizures in people with a severe form of epilepsy called Lennox-Gastaut syndrome. It will involve about 260 children and adults, comparing the drug to a placebo to see if it is safe and effective. The main goal is to see if it lowers the number of major seizures people experience.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LENNOX GASTAUT SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Minnesota Epilepsy Group, P.A.
RECRUITINGRoseville, Minnesota, 55113, United States
Contact Phone: •••-•••-••••
-
Neurology Center for Epilepsy and Seizures
RECRUITINGMarlboro, New Jersey, 07746, United States
Contact Phone: •••-•••-••••
-
On-Site Clinical Solution
RECRUITINGCharlotte, North Carolina, 28211, United States
Contact Phone: •••-•••-••••
-
Rare Disease Research
RECRUITINGKissimmee, Florida, 34746, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.